Calidi Biotherapeutics (CLDI) Selling, General & Administrative (2022 - 2026)
Calidi Biotherapeutics (CLDI) posted Selling, General & Administrative of $1.59 million for Q2 2026, down 48.2% from $3.07 million a year earlier.
Powered by 
Analysis
Calidi Biotherapeutics (CLDI) Selling, General & Administrative (2022 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Calidi Biotherapeutics was $9.46 million, down 14.0% year-over-year; for FY2025, it was $10.5 million, down 18.6% from FY2024.
- Annual Selling, General & Administrative shows a three-year compound annual growth rate of -12.9% (FY2022 to FY2025).
- In prior years, Calidi Biotherapeutics' Selling, General & Administrative was $12.9 million in FY2024 (-19.3%), $15.98 million in FY2023 (+0.5%) and $15.9 million in FY2022.
- The Q2 2026 figure stands as the lowest quarterly Selling, General & Administrative in data going back to Q3 2022.
- The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q4 2023, with growth of 141.7%; the weakest was Q4 2024, with a decline of 62.3%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.13 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 6.29 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.09 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.89 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.11 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.68 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.64 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.28 Bn |
| 10 | Calidi Biotherapeutics | 991,199.98 | -25.74 Mn | - | 1.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.59 Mn |
| Mar 31, 2026 | 1.60 Mn |
| Dec 31, 2025 | 2.11 Mn |
| Sep 30, 2025 | 2.69 Mn |
| Jun 30, 2025 | 3.07 Mn |
| Mar 31, 2025 | 2.64 Mn |
| Dec 31, 2024 | 2.21 Mn |
| Sep 30, 2024 | 3.07 Mn |
| Jun 30, 2024 | 3.61 Mn |
| Mar 31, 2024 | 4.01 Mn |
| Dec 31, 2023 | 5.86 Mn |
| Sep 30, 2023 | 3.97 Mn |
| Jun 30, 2023 | 3.36 Mn |
| Mar 31, 2023 | 2.79 Mn |
| Dec 31, 2022 | 2.43 Mn |
| Sep 30, 2022 | 5.04 Mn |
API Access
Calidi Biotherapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CLDI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "CLDI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CLDI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();